D. De Gregorio

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
D. De Gregorio, Danilo De Gregorio
Publication record
28 papers · 1,694 citations · H-index 21

PAPERS

Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective?
20244 citationsauthor #5
The central role of the Thalamus in psychosis, lessons from neurodegenerative diseases and psychedelics
202325 citationsauthor #4
Acanthoscurria gomesiana spider‐derived Mygalin in the prelimbic prefrontal cortex modulates neuropathic pain and depression comorbid
20233 citationsauthor #4
Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence
202313 citationsauthor #3
Repeated lysergic acid diethylamide (LSD) reverses stress-induced anxiety-like behavior, cortical synaptogenesis deficits and serotonergic neurotransmission decline
202265 citationsauthor #1
Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder
202230 citationsauthor #3
Modulation of DNA methylation and protein expression in the prefrontal cortex by repeated administration of D-lysergic acid diethylamide (LSD): Impact on neurotropic, neurotrophic, and neuroplasticity signaling.
202226 citationsauthor #9
Supraspinal melatonin MT2 receptor agonism alleviates pain via a neural circuit that recruits mu opioid receptors
202211 citationsauthor #2
A century of research on psychedelics: A scientometric analysis on trends and knowledge maps of hallucinogens, entactogens, entheogens and dissociative drugs.
202246 citationsauthor #15
Effects of repeated lysergic acid diethylamide (LSD) on the mouse brain endocannabinoidome and gut microbiome
202226 citationsauthor #9
Lysergic acid diethylamide (LSD) promotes social behavior through mTORC1 in the excitatory neurotransmission
202197 citationsauthor #1
Lysergic acid diethylamide differentially modulates the reticular thalamus, mediodorsal thalamus, and infralimbic prefrontal cortex: An in vivo electrophysiology study in male mice
202130 citationsauthor #2
Lysergic acid diethylamide (LSD) promotes social behaviour through 5-HT2A and ampa in the medial prefrontal cortex (MPFC)
20214 citationsauthor #3
Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine
2020145 citationsauthor #1
Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
2020183 citationsauthor #2
Antidepressant actions of ketamine engage cell-specific translation via eIF4E
2020106 citationsauthor #2
A Key Role for Prefrontocortical Small Conductance Calcium-Activated Potassium Channels in Stress Adaptation and Rapid Antidepressant Response.
20209 citationsauthor #4
Effects of Chronic Exposure to Low-Dose delta-9-Tetrahydrocannabinol in Adolescence and Adulthood on Serotonin/Norepinephrine Neurotransmission and Emotional Behavior
202030 citationsauthor #1
Nociceptive responses in melatonin MT2 receptor knockout mice compared to MT1 and double MT1/MT2 receptor knockout mice
202021 citationsauthor #4
Dysfunction of serotonergic activity and emotional responses across the light‐dark cycle in mice lacking melatonin MT2 receptors
202028 citationsauthor #2
Melatonin MT1 and MT2 Receptors Exhibit Distinct Effects in the Modulation of Body Temperature across the Light/Dark Cycle
201925 citationsauthor #4
Melatonin MT1 receptor as a novel target in neuropsychopharmacology: MT1 ligands, pathophysiological and therapeutic implications, and perspectives.
201942 citationsauthor #3
d-Lysergic acid diethylamide, psilocybin, and other classic hallucinogens: Mechanism of action and potential therapeutic applications in mood disorders.
201880 citationsauthor #1
Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain
2018318 citationsauthor #1
Translational control of depression-like behavior via phosphorylation of eukaryotic translation initiation factor 4E
201870 citationsauthor #3
Targeting Melatonin MT2 Receptors: A Novel Pharmacological Avenue for Inflammatory and Neuropathic Pain.
201760 citationsauthor #2
d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology
2016107 citationsauthor #1
The hallucinogen d-lysergic diethylamide (LSD) decreases dopamine firing activity through 5-HT1A, D2 and TAAR1 receptors.
201693 citationsauthor #1

TIMELINE

2016 200 citations

2017 60 citations

2018 468 citations

2019 67 citations

2020 522 citations

2021 131 citations

2022 204 citations

2023 41 citations

2024 4 citations

D. De Gregorio

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT